Comparative study on morning and evening regimens of fleroxacin for the treatment of complicated urinary tract infections

M. Takeda, K. Noguchi, M. Masuda, M. Yao, Y. Kinoshita, M. Hosaka, S. Fukushima, C. Kawasaki, T. Murai, Y. Satomi, M. Fukuda, T. Kodaira, K. Miyai, K. Sano, T. Ishido, K. Tanaka, K. Sato, H. Kanno, Y. Senga, H. KumagaiT. Takahashi, K. Saito, H. Fukuoka, K. Kitami, H. Shimura, H. Shiozaki, H. Miyamoto

Research output: Contribution to journalArticle

Abstract

We performed a prospective randomized study to evaluate the effectiveness and safety of once-daily administrations of fleroxacin (FLRX) for the treatment of complicated urinary tract infections. A comparative study was conducted with administration of 200mg FLRX once a day, after breakfast or after dinner, for 7 days. Of a total 167 cases, 62 cases in the morning-administration group and 61 cases in the evening-administration group were evaluated under the criteria proposed by the Japanese UTI committee. The overall clinical efficacy was 67.7% in the morning group and 55.7% in the evening group. No significant difference was revealed between these two groups. Clinical adverse reactions were recognized in 3 cases in the morning group (85 cases) and 1 case in the evening group (80 cases). Abnormal laboratory findings were found in one case in the morning group. As a result, there were no significant differences in the effectiveness and safety of FLRX, regardless of the timing of administration. It was suggested that the timing of the administration of FLRX can be arranged to fit in with the lifestyle of the patients and the drug shows good compliance.

Original languageEnglish (US)
Pages (from-to)733-744
Number of pages12
JournalNishinihon Journal of Urology
Volume60
Issue number10
StatePublished - 1998
Externally publishedYes

Fingerprint

Fleroxacin
Urinary Tract Infections
Safety
Breakfast
Therapeutics
Meals
Life Style
Prospective Studies
Pharmaceutical Preparations

Keywords

  • Complicated urinary tract infection
  • Fleroxacin
  • FLRX

ASJC Scopus subject areas

  • Urology

Cite this

Takeda, M., Noguchi, K., Masuda, M., Yao, M., Kinoshita, Y., Hosaka, M., ... Miyamoto, H. (1998). Comparative study on morning and evening regimens of fleroxacin for the treatment of complicated urinary tract infections. Nishinihon Journal of Urology, 60(10), 733-744.

Comparative study on morning and evening regimens of fleroxacin for the treatment of complicated urinary tract infections. / Takeda, M.; Noguchi, K.; Masuda, M.; Yao, M.; Kinoshita, Y.; Hosaka, M.; Fukushima, S.; Kawasaki, C.; Murai, T.; Satomi, Y.; Fukuda, M.; Kodaira, T.; Miyai, K.; Sano, K.; Ishido, T.; Tanaka, K.; Sato, K.; Kanno, H.; Senga, Y.; Kumagai, H.; Takahashi, T.; Saito, K.; Fukuoka, H.; Kitami, K.; Shimura, H.; Shiozaki, H.; Miyamoto, H.

In: Nishinihon Journal of Urology, Vol. 60, No. 10, 1998, p. 733-744.

Research output: Contribution to journalArticle

Takeda, M, Noguchi, K, Masuda, M, Yao, M, Kinoshita, Y, Hosaka, M, Fukushima, S, Kawasaki, C, Murai, T, Satomi, Y, Fukuda, M, Kodaira, T, Miyai, K, Sano, K, Ishido, T, Tanaka, K, Sato, K, Kanno, H, Senga, Y, Kumagai, H, Takahashi, T, Saito, K, Fukuoka, H, Kitami, K, Shimura, H, Shiozaki, H & Miyamoto, H 1998, 'Comparative study on morning and evening regimens of fleroxacin for the treatment of complicated urinary tract infections', Nishinihon Journal of Urology, vol. 60, no. 10, pp. 733-744.
Takeda, M. ; Noguchi, K. ; Masuda, M. ; Yao, M. ; Kinoshita, Y. ; Hosaka, M. ; Fukushima, S. ; Kawasaki, C. ; Murai, T. ; Satomi, Y. ; Fukuda, M. ; Kodaira, T. ; Miyai, K. ; Sano, K. ; Ishido, T. ; Tanaka, K. ; Sato, K. ; Kanno, H. ; Senga, Y. ; Kumagai, H. ; Takahashi, T. ; Saito, K. ; Fukuoka, H. ; Kitami, K. ; Shimura, H. ; Shiozaki, H. ; Miyamoto, H. / Comparative study on morning and evening regimens of fleroxacin for the treatment of complicated urinary tract infections. In: Nishinihon Journal of Urology. 1998 ; Vol. 60, No. 10. pp. 733-744.
@article{87a13d30f8be4cb0bfecc6d78a8d17df,
title = "Comparative study on morning and evening regimens of fleroxacin for the treatment of complicated urinary tract infections",
abstract = "We performed a prospective randomized study to evaluate the effectiveness and safety of once-daily administrations of fleroxacin (FLRX) for the treatment of complicated urinary tract infections. A comparative study was conducted with administration of 200mg FLRX once a day, after breakfast or after dinner, for 7 days. Of a total 167 cases, 62 cases in the morning-administration group and 61 cases in the evening-administration group were evaluated under the criteria proposed by the Japanese UTI committee. The overall clinical efficacy was 67.7{\%} in the morning group and 55.7{\%} in the evening group. No significant difference was revealed between these two groups. Clinical adverse reactions were recognized in 3 cases in the morning group (85 cases) and 1 case in the evening group (80 cases). Abnormal laboratory findings were found in one case in the morning group. As a result, there were no significant differences in the effectiveness and safety of FLRX, regardless of the timing of administration. It was suggested that the timing of the administration of FLRX can be arranged to fit in with the lifestyle of the patients and the drug shows good compliance.",
keywords = "Complicated urinary tract infection, Fleroxacin, FLRX",
author = "M. Takeda and K. Noguchi and M. Masuda and M. Yao and Y. Kinoshita and M. Hosaka and S. Fukushima and C. Kawasaki and T. Murai and Y. Satomi and M. Fukuda and T. Kodaira and K. Miyai and K. Sano and T. Ishido and K. Tanaka and K. Sato and H. Kanno and Y. Senga and H. Kumagai and T. Takahashi and K. Saito and H. Fukuoka and K. Kitami and H. Shimura and H. Shiozaki and H. Miyamoto",
year = "1998",
language = "English (US)",
volume = "60",
pages = "733--744",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "10",

}

TY - JOUR

T1 - Comparative study on morning and evening regimens of fleroxacin for the treatment of complicated urinary tract infections

AU - Takeda, M.

AU - Noguchi, K.

AU - Masuda, M.

AU - Yao, M.

AU - Kinoshita, Y.

AU - Hosaka, M.

AU - Fukushima, S.

AU - Kawasaki, C.

AU - Murai, T.

AU - Satomi, Y.

AU - Fukuda, M.

AU - Kodaira, T.

AU - Miyai, K.

AU - Sano, K.

AU - Ishido, T.

AU - Tanaka, K.

AU - Sato, K.

AU - Kanno, H.

AU - Senga, Y.

AU - Kumagai, H.

AU - Takahashi, T.

AU - Saito, K.

AU - Fukuoka, H.

AU - Kitami, K.

AU - Shimura, H.

AU - Shiozaki, H.

AU - Miyamoto, H.

PY - 1998

Y1 - 1998

N2 - We performed a prospective randomized study to evaluate the effectiveness and safety of once-daily administrations of fleroxacin (FLRX) for the treatment of complicated urinary tract infections. A comparative study was conducted with administration of 200mg FLRX once a day, after breakfast or after dinner, for 7 days. Of a total 167 cases, 62 cases in the morning-administration group and 61 cases in the evening-administration group were evaluated under the criteria proposed by the Japanese UTI committee. The overall clinical efficacy was 67.7% in the morning group and 55.7% in the evening group. No significant difference was revealed between these two groups. Clinical adverse reactions were recognized in 3 cases in the morning group (85 cases) and 1 case in the evening group (80 cases). Abnormal laboratory findings were found in one case in the morning group. As a result, there were no significant differences in the effectiveness and safety of FLRX, regardless of the timing of administration. It was suggested that the timing of the administration of FLRX can be arranged to fit in with the lifestyle of the patients and the drug shows good compliance.

AB - We performed a prospective randomized study to evaluate the effectiveness and safety of once-daily administrations of fleroxacin (FLRX) for the treatment of complicated urinary tract infections. A comparative study was conducted with administration of 200mg FLRX once a day, after breakfast or after dinner, for 7 days. Of a total 167 cases, 62 cases in the morning-administration group and 61 cases in the evening-administration group were evaluated under the criteria proposed by the Japanese UTI committee. The overall clinical efficacy was 67.7% in the morning group and 55.7% in the evening group. No significant difference was revealed between these two groups. Clinical adverse reactions were recognized in 3 cases in the morning group (85 cases) and 1 case in the evening group (80 cases). Abnormal laboratory findings were found in one case in the morning group. As a result, there were no significant differences in the effectiveness and safety of FLRX, regardless of the timing of administration. It was suggested that the timing of the administration of FLRX can be arranged to fit in with the lifestyle of the patients and the drug shows good compliance.

KW - Complicated urinary tract infection

KW - Fleroxacin

KW - FLRX

UR - http://www.scopus.com/inward/record.url?scp=0031738142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031738142&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031738142

VL - 60

SP - 733

EP - 744

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 10

ER -